Nykode Therapeutics Feed

2026-01-30 22:44:48 Nykode Therapeutics - Grant of share options

2026-01-21 11:55:00 Nykode Therapeutics ASA - Minutes of Extraordinary General Meeting 2,49 NOK | +0,89% | 0,57 MNOK

2025-12-30 17:49:00 NYKD: Financial calendar

2025-12-19 14:45:00 NYKD: Nykode Therapeutics to Present Interim Data from the VB-C-03 trial at the 10th International Congress on Innovative Approaches in Head & Neck Oncology (ICHNO) on March 20, 2026 2,26 NOK | -0,44% | 1,34 MNOK

2025-12-18 07:00:00 Nykode Therapeutics ASA - Notice of Extraordinary General Meeting 2,27 NOK | -2,24% | 2,09 MNOK

2025-12-18 07:00:00 NYKD: Nykode Therapeutics Strengthens Board with the Nomination of Dr. Barbara Krebs-Pohl as New Chair of the Board and Dr. John Beadle as Board Member 2,27 NOK | -2,24% | 2,09 MNOK

2025-11-24 16:40:00 Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 2,13 NOK | -3,01% | 2,32 MNOK

2025-11-24 07:00:00 Nykode Therapeutics - Quarterly Report Q3 2025 2,20 NOK | +3,58% | 1,31 MNOK

2025-11-13 08:00:00 Nykode Therapeutics - Invitation to Q3 2025 Financial Results Presentation 2,30 NOK | +2,77% | 0,48 MNOK

2025-11-05 07:00:00 NYKD: Nykode Therapeutics to Present Data on the Strength of the Neoantigen Selection Method from Two Clinical Trials at the Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting 2,75 NOK | +8,10% | 4,22 MNOK

2025-11-04 07:00:00 NYKD: Nykode Therapeutics Strengthens Intellectual Property Portfolio with New U.S. Patent for the Neoantigen Selection Method for VB10.NEO, Nykode's Individualized Neoantigen Therapy 2,54 NOK | +9,75% | 2,19 MNOK

2025-10-14 08:17:48 Disclosure of Large Shareholding - Nykode Therapeutics ASA 2,12 NOK | -6,94% | 4,31 MNOK

2025-10-10 17:44:29 Nykode Therapeutics - Grant of Share Options

2025-10-10 14:00:27 Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 2,11 NOK | +21,40% | 8,35 MNOK

2025-10-10 12:36:39 Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 2,11 NOK | +21,40% | 8,35 MNOK

2025-10-09 20:27:08 NYKD: Financial calendar 2,11 NOK | +21,40% | 8,35 MNOK

2025-08-27 07:01:00 NYKD: Nykode Announces Updated Strategy to Increase Value for Patients and Shareholders, Prioritizing VB10.16 as the Lead Value Driver 1,56 NOK | -9,83% | 3,81 MNOK

2025-08-27 07:00:00 Nykode Therapeutics - Quarterly report Q2 2025 1,56 NOK | -9,83% | 3,81 MNOK

2025-08-20 08:00:00 Nykode Therapeutics - Invitation to Q2 2025 Financial Results Presentation and Strategy Update 1,78 NOK | -0,45% | 0,26 MNOK

2025-07-09 18:15:00 Nykode Therapeutics - Grant of Share Options 1,79 NOK | -0,88% | 0,20 MNOK

2025-07-04 16:41:54 NYKD: Financial calendar

2025-05-28 07:00:00 Nykode Therapeutics - Quarterly report Q1 2025 1,90 NOK | -1,09% | 5,01 MNOK

2025-05-27 07:00:00 Nykode Therapeutics ASA - Ex-dividend NOK 1.00 today 1,92 NOK | -33,39% | 5,40 MNOK

2025-05-26 16:51:34 Nykode Therapeutics - invitation to Q1 2025 financial results presentation 1,92 NOK | -33,39% | 5,40 MNOK

2025-05-26 11:25:00 Nykode Therapeutics ASA - Minutes of Annual General Meeting 2,88 NOK | +7,61% | 16,6 MNOK

2025-05-23 07:00:00 NYKD: Nykode Therapeutics Highlights New Data in Two Poster Presentations at the 2025 ASCO Annual Meeting 2,68 NOK | +2,13% | 7,22 MNOK

2025-05-05 08:30:00 Nykode Therapeutics ASA - Notice of Annual General Meeting 2,54 NOK | +3,08% | 2,53 MNOK

2025-04-29 07:00:00 Nykode Therapeutics - Annual Report 2024 2,49 NOK | +7,61% | 4,48 MNOK

2025-04-28 19:17:03 Nykode Therapeutics - Key information relating to proposed cash dividend 2,49 NOK | +7,61% | 4,48 MNOK

2025-04-23 15:50:00 Nykode Therapeutics ASA - Minutes of Extraordinary General Meeting 2,46 NOK | +2,24% | 1,61 MNOK

2025-04-15 07:20:00 NYKD: Nykode announces that Michael Engsig, CEO 2,54 NOK | +13,19% | 17,2 MNOK

2025-04-11 18:59:52 NYKD: Financial calendar

2025-04-02 09:40:00 Nykode Therapeutics ASA - Notice of Extraordinary General Meeting 2,27 NOK | +4,03% | 2,78 MNOK

2025-03-27 16:56:59 Nykode Therapeutics - Mandatory Notification of Trade by Closely Associated Party of a Primary Insider 2,29 NOK | +9,16% | 15,3 MNOK

2025-03-27 14:15:00 OSLO BØRS - TRADING RESUMPTION 2,10 NOK | -6,26% | 16,8 MNOK

2025-03-27 13:33:40 Nykode Therapeutics - resignation of Chair of the Board, Board Members, Chief Executive Officer, Chief Scientific Officer and Chief Financial Officer 2,10 NOK | -6,26% | 16,8 MNOK

2025-03-27 13:30:53 OSLO BØRS - TRADING SUSPENSION 2,10 NOK | -6,26% | 16,8 MNOK

2025-02-27 20:30:00 NYKD: Nykode Therapeutics Announces Preclinical Data Highlighting its Immune Tolerance Platform's Ability to Modulate Multiple Key Immune Components in Autoimmune Disease 2,56 NOK | +2,72% | 2,87 MNOK

2025-02-26 07:00:00 Nykode Therapeutics - Quarterly report Q4 2024 2,59 NOK | +1,41% | 7,10 MNOK

2025-02-14 16:05:27 Nykode Therapeutics - invitation to Q4 2024 financial results presentation 2,42 NOK | +6,24% | 2,08 MNOK

2025-01-08 10:50:00 NYKD: Nykode Therapeutics Announces Publication of Phase 2 VB-C-02 Data Confirming Prolonged Benefit and Definitive Vaccination Effects 2,92 NOK | +3,69% | 22,4 MNOK

2024-12-30 19:47:29 NYKD: Financial calendar

2024-12-30 13:35:00 Nykode Therapeutics - Streamlining Board of Directors 3,05 NOK | +2,42% | 5,49 MNOK

2024-12-20 14:19:44 Nykode Therapeutics - Mandatory Notification of Trade 2,89 NOK | -3,41% | 5,48 MNOK

2024-12-04 19:00:00 NYKD: Nykode Therapeutics Presents New Data on Individualized Cancer Immunotherapy at the Personalized Cancer Vaccines Summit 2,95 NOK | +4,31% | 20,1 MNOK

2024-11-27 00:05:00 Nykode Therapeutics - Quarterly report Q3 2024 2,69 NOK | +5,90% | 6,36 MNOK

2024-11-20 18:00:00 Nykode Therapeutics - invitation to Q3 2024 financial results presentation 2,77 NOK | +0,73% | 5,16 MNOK

2024-11-08 15:18:40 Nykode Therapeutics ASA - Mandatory Notification of Trade by Closely Associated Party of a Primary Insider 2,40 NOK | -44,08% | 65,7 MNOK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Nykode Therapeutics

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden